Comparison

Riluzole European Partner

Item no. TMO-T0349-200mg
Manufacturer TargetMol
CASRN 1744-22-5
Amount 200mg
Category
Type Molecules
Specific against other
Purity 0,98
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Riluzole, PK 26124; Rilutek, GluR antagonist; Sodium Channel inhibitor
Similar products 1744-22-5
Available
Description
Riluzole is a sodium channel protein inhibitor and potent neuroprotective agent. It has been shown to preferentially block tetrodotoxin-sensitive sodium channels, which are associated with damaged neurons. In the presence of negative potentials, Riluzole was shown to also block tetrodotoxin-resistant sodium channels. It has been reported that Riluzole exerts its neuroprotective action under ischemic conditions, thereby suppressing glutamatergic receptor stimulation and calcium influx. Research shows that this product activates the TREK family of potassium channels and directly affects the glutamatergic system. Riluzole inhibits glutamate release from presynaptic terminals and increases Na+-dependent glutamate uptake in rat cortical synaptosomes. Riluzole blocks voltage-dependent Na+ channels and inhibits GABA uptake by striatal synaptosomes.
Formulate
C8H5F3N2OS
Shipping temperature
Cool Pack
Smeles
NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
Storage Temperature
-20° C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close